OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of a fourth SARS‐CoV‐2 vaccine dose in previously infected individuals from Austria
Alena Chalupka, Lukas Richter, Ali Chakeri, et al.
European Journal of Clinical Investigation (2023) Vol. 54, Iss. 3
Open Access | Times Cited: 15

Showing 15 citing articles:

Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
Alberto Rubio‐Casillas, David E. Cowley, Mikolaj Raszek, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131427-131427
Closed Access | Times Cited: 8

COVID-19 Case Fatality Rate and Infection Fatality Rate from 2020 to 2023: Nationwide Analysis in Austria
Uwe Riedmann, Alena Chalupka, Lukas Richter, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 4, pp. 102698-102698
Open Access

All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data
Marco Alessandria, Giovanni Malatesta, Giovanni Di Palmo, et al.
F1000Research (2025) Vol. 13, pp. 886-886
Open Access

Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategies
Mariana Barosa, John P. A. Ioannidis, Vinay Prasad
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 3

Effectiveness of the first and second SARS-CoV-2 vaccine dose: a nationwide cohort study from Austria on hybrid versus natural immunity
Alena Chalupka, Uwe Riedmann, Lukáš Richter, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 10
Open Access | Times Cited: 2

Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper
Ullrich Bethe, Zoi Dorothea Pana, Christian Drosten, et al.
Infection (2024)
Open Access | Times Cited: 1

All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data
Marco Alessandria, Giovanni Malatesta, Giovanni Di Palmo, et al.
F1000Research (2024) Vol. 13, pp. 886-886
Open Access | Times Cited: 1

Re: ‘Effectiveness of a fourth SARS‐CoV‐2 vaccine dose in previously infected individuals’
Hinpetch Daungsupawong, Viroj Wiwanitkit
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 5
Closed Access

Co-Mutations and Possible Variation Tendency of the Spike RBD and Membrane Protein in SARS-CoV-2 by Machine Learning
Qiushi Ye, He Wang, Fanding Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4662-4662
Open Access

Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection
Huiling Zheng, Shenggen Wu, Chen Wu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access

Vaccination against COVID-19 in a post-pandemic era
Felippe Lazar Neto, Adrián Ceccato, Otávio T. Ranzani
European Respiratory Society eBooks (2024)
Closed Access

Long-term effectiveness of an ultra-rapid rollout vaccination campaign with BNT162b2 on the incidence of SARS-CoV-2 infection
Lena Tschiderer, Hanna Innerhofer, Lisa Seekircher, et al.
iScience (2024) Vol. 27, Iss. 11, pp. 111117-111117
Closed Access

Page 1

Scroll to top